Company News in the Life Science Industry

»

Reset 

AbbVie Inc. - Rule 2.10 Announcement - Relevant Securities in Issue

NORTH CHICAGO, Ill., Feb. 25, 2020 /PRNewswire/ -- In accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, AbbVie Inc. confirms that as of February 21, 2020 its issued share capital, excluding treasury shares, is comprised of 1,481,908,359 shares of common stock... Read more ››

By: PR Newswire Association LLC. - 25 Feb 2020

Pinpoint Science Announces Collaboration with Analog Devices to Advance Novel Nanosensors for Pathogen Detection

SAN FRANCISCO, Feb. 25, 2020 /PRNewswire/ -- Pinpoint Science Inc. today announced a strategic collaboration with Read more ››

By: PR Newswire Association LLC. - 25 Feb 2020

Vir Biotechnology to Present at 40th Annual Cowen Healthcare Conference

Read more ››
By: GlobenewsWire - 25 Feb 2020
Related companies:  Delta-Vir GmbH | Vir Biotechnology, Inc.

Excel Nuclear Oncology Center initiates the first Lu-177 DOTATOC PRRT clinical trial for the PUT-Neuroendocrine Tumors, in U.S.

Read more ››
By: GlobenewsWire - 25 Feb 2020
Related companies:  RadioMedix Inc.

FDA accepts Roche’s Biologics License Application for fixed-dose subcutaneous combination of Perjeta and Herceptin for HER2-positive breast cancer

Read more ››
By: GlobenewsWire - 25 Feb 2020
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

IO Biotech Announces Positive Outcome of Interim Analysis of Phase 2 Randomized Trial in First Line Non-small Cell Lung Cancer

COPENHAGEN, Denmark, Feb. 25, 2020 /PRNewswire/ -- IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune modulating anti-cancer therapies based on its proprietary T-win® technology, announced the successful outcome of a scheduled interim analysis of the ongoing Phase... Read more ››

By: PR Newswire Association LLC. - 25 Feb 2020

Axiom Real-Time Metrics Set to Attend Biocom’s 10th Annual Global Life Science Partnering Conference in La Jolla, CA

Read more ››
By: GlobenewsWire - 25 Feb 2020
Related companies:  Axiom Real-Time Metrics Inc.

Coronavirus Update: FDA steps to ensure quality of foreign products

SILVER SPRING, Md., Feb. 24, 2020 /PRNewswire/ -- Recently, we provided an update on FDA-wide activities we are engaged in related to the novel coronavirus outbreak: COVID-19. We continue to take a multi-pronged approach to this public health emergency, including focusing on actively facilitating... Read more ››

By: PR Newswire Association LLC. - 25 Feb 2020
Related companies:  U.S. Food and Drug Administration

FDA approves first generic of ProAir HFA

SILVER SPRING, Md., Feb. 24, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration today approved the first generic of ProAir HFA (albuterol sulfate) Inhalation Aerosol for the treatment or prevention of bronchospasm in patients four years of age and older with reversible obstructive airway... Read more ››

By: PR Newswire Association LLC. - 25 Feb 2020
Related companies:  U.S. Food and Drug Administration

The Valens Company Reports Record Financial Performance in the Fourth Quarter and Fiscal Year Ended November 30, 2019 with Q4 Adjusted EBITDA(1) of $17.7 Million

KELOWNA, BC, Feb. 24, 2020 /CNW/ - Valens GroWorks Corp. (TSXV: VLNS) (OTCQX: VLNCF) (the "Company", "Valens" or "The Valens Company"), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, is pleased to... Read more ››

By: PR Newswire Association LLC. - 25 Feb 2020

American College of Rheumatology Releases First Guideline to Address Reproductive Health for Patients with Rheumatic Diseases

Read more ››
By: GlobenewsWire - 24 Feb 2020

DBV Technologies to Present Detailed Safety and Efficacy Data of Viaskin Peanut at AAAAI 2020

Read more ››
By: GlobenewsWire - 24 Feb 2020
Related companies:  DBV Technologies S.A.

Axogen, Inc. Reports Fourth Quarter and Full-Year 2019 Financial Results

Read more ››
By: GlobenewsWire - 24 Feb 2020
Related companies:  AxoGen, Inc.

Retrophin Reports Fourth Quarter and Full Year 2019 Financial Results

Read more ››
By: GlobenewsWire - 24 Feb 2020
Related companies:  Retrophin, Inc

Axovant Gene Therapies Announces Closing of $74.7 Million Public Offering of Common Shares and Prefunded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Read more ››
By: GlobenewsWire - 24 Feb 2020
Related companies:  Axovant Gene Therapies

Opiant Pharmaceuticals to Report Fourth Quarter 2019 Financial Results and Host Conference Call and Webcast on Wednesday, March 4

Read more ››
By: GlobenewsWire - 24 Feb 2020
Related companies:  Opiant Pharmaceuticals, Inc.

Merit Medical Reports Earnings for Fourth Quarter and Year Ended December 31, 2019, Gives FY 2020 Guidance

Read more ››
By: GlobenewsWire - 24 Feb 2020
Related companies:  Merit Medical Systems, Inc.

Quotient Limited Reports Concordance Data from Extended Serological Disease Screening Benchmark Study

Read more ››
By: GlobenewsWire - 24 Feb 2020
Related companies:  QUOTIENT LIMITED

Dynavax to Report Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on March 11

Read more ››
By: GlobenewsWire - 24 Feb 2020
Related companies:  Dynavax Technologies Corporation

T2 Biosystems Announces Fourth Quarter and Full Year 2019 Financial Results

Read more ››
By: GlobenewsWire - 24 Feb 2020
Related companies:  T2 Biosystems, Inc.
«  1 2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies